NasdaqCM - Delayed Quote USD
Vaxart, Inc. (VXRT)
0.4168
-0.0332
(-7.38%)
At close: June 3 at 4:00:00 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 2.37M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
LO STEVEN Chief Executive Officer | Purchase at price 0.49 per share. | Indirect | 49,000 | May 19, 2025 |
GRASMAN JEROEN NICOLAAS Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | May 19, 2025 |
LO STEVEN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 24, 2025 |
TUCKER SEAN N. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 24, 2025 |
CUMMINGS JAMES F. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 24, 2025 |
BERG EDWARD B General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 24, 2025 |
LEE PHILLIP E. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 24, 2025 |
FINNEY KEVIN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 28, 2025 |
WATSON WILLIAM MARK Director | Purchase at price 0.68 per share. | Direct | 13,578 | Jun 18, 2024 |
HERON ELAINE J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
FINNEY MICHAEL J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
WATSON WILLIAM MARK Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
WHEADON DAVID E. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
YEDID ROBERT A. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2024 |
LO STEVEN Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 18, 2024 |
TUCKER SEAN N. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 18, 2024 |
CUMMINGS JAMES F. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 18, 2024 |
BERG EDWARD B General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 18, 2024 |
LEE PHILLIP E. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 18, 2024 |
HERON ELAINE J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 26, 2023 |
FINNEY MICHAEL J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 26, 2023 |
WATSON WILLIAM MARK Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 26, 2023 |
WHEADON DAVID E. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 26, 2023 |
YEDID ROBERT A. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 26, 2023 |
LEE PHILLIP E. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 12, 2023 |
TUCKER SEAN N. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 17, 2023 |
FLOROIU CEZAR ANDREI Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 17, 2023 |
CUMMINGS JAMES F. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 17, 2023 |
BERG EDWARD B General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 17, 2023 |
LEE PHILLIP E. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 17, 2023 |
LEE PHILLIP E. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 17, 2023 |
WATSON WILLIAM MARK Director | Purchase at price 0.76 per share. | Direct | 15,140 | Dec 28, 2022 |
LEE PHILLIP E. Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 16, 2022 |
HERON ELAINE J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 25, 2022 |
YEDID ROBERT A. Director | Stock Gift at price 0.00 per share. | Direct | 0 | Aug 24, 2022 |
YEDID ROBERT A. Director | Conversion of Exercise of derivative security at price 0.31 - 2.39 per share. | Direct | 24,774 | Aug 19, 2022 |
DAVIS TODD CLIFTON Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 4, 2022 |
FINNEY MICHAEL J Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 4, 2022 |
WATSON WILLIAM MARK Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 4, 2022 |
CHERRINGTON JULIE M Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 4, 2022 |
WHEADON DAVID E. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 4, 2022 |
YEDID ROBERT A. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 4, 2022 |
AHMAD FUAD Chief Financial Officer | Purchase at price 3.22 per share. | Direct | 16,100 | Jun 22, 2022 |
TUCKER SEAN N. Officer | Conversion of Exercise of derivative security at price 0.77 per share. | Direct | 30,800 | Apr 22, 2022 |
TUCKER SEAN N. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 28, 2022 |
FLOROIU CEZAR ANDREI Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 28, 2022 |
CUMMINGS JAMES F. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 28, 2022 |
YEDID ROBERT A. Director | Sale at price 6.01 per share. | Indirect | 9,015 | Jan 10, 2022 |
DAVIS TODD CLIFTON Director | Stock Gift at price 0.00 per share. | Direct | 0 | Dec 22, 2021 |
ECHERD MARGARET A Officer | Sale at price 8.00 per share. | Direct | 28,816 | Nov 30, 2021 |
Related Tickers
INO Inovio Pharmaceuticals, Inc.
2.1200
+0.95%
IBIO iBio, Inc.
0.8419
+1.43%
OCGN Ocugen, Inc.
0.8516
+1.72%
SRNE Sorrento Therapeutics, Inc.
0.0013
0.00%
NVAX Novavax, Inc.
7.26
+2.69%
JAGX Jaguar Health, Inc.
4.1700
+2.71%
GOVX GeoVax Labs, Inc.
1.0500
+0.96%
TNXP Tonix Pharmaceuticals Holding Corp.
40.45
+6.28%
ALT Altimmune, Inc.
5.42
+2.26%
CVAC CureVac N.V.
4.7000
+1.51%